Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*
Platelet Rich Plasma Market by Product (Pure PRP, Leukocyte Rich PRP, and Leukocyte Rich Fibrin), by Origin (Autologous PRP, Allogeneic PRP, and Homologous PRP), and by Application (Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery, and Others) - Global Opportunity Analysis and Industry Forecast, 2021-2028
| A02408 | Pages: NA | Feb 2021 | 4187 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA | Formats*: | |
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Platelet Rich Plasma Market
Request Now !Platelet rich plasma (PRP) is derived from blood. It is produced when the human blood is spun down and platelet rich plasma is separated that have a concentration of platelets above the normal values. Platelets help in blood clotting as well as enhance the healing of tendons, muscles, and ligaments. PRP is used in different surgeries such as augmentation of shoulder rotator cuff and tendon repair.
Platelets are extremely rich in healing factors and connective tissue growth.
The major factors that enhance the market growth are growth in geriatric population, increase in incidence of sports and orthopedic injuries, rise in number of cosmetic surgical procedures, technological advancements, and increase in awareness regarding PRP therapies. However, difficulty in quality control of test results, thereby restrain the market growth.
The market is segmented based on product, origin, application, and geography. By product, this market is categorized into pure PRP, leukocyte rich PRP, and leukocyte rich fibrin. By origin, it is classified into autologous PRP, allogeneic PRP, and homologous PRP. By application, it is divided into orthopedic surgery, cosmetic surgery, general surgery, neurosurgery, and others. By geography, it is studied across North America, Europe, Asia Pacific, and LAMEA.
Key Benefits
- Comprehensive analysis of factors that drive and restrict the growth of the global PRP market is provided.
- The projections in the market are made by studying the current market trends and future market potential for the period (20172023) in terms of value.
- Extensive analysis by technology and application helps understand the various trends and prevailing opportunities in the respective market
- Key market players within the global PRP market are profiled in the market and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the global PRP market.
- Comprehensive analysis of all regions are provided that determines the prevailing opportunities in these geographies.
Platelet Rich Plasma Market Key Segments:
By Product
- Pure PRP
- Leukocyte Rich PRP
- Leukocyte Rich Fibrin
By Origin
- Autologous PRP
- Allogeneic PRP
- Homologous PRP
By Application
- Orthopedic Surgery
- Cosmetic Surgery
- General Surgery
- Neurosurgery
- Others
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
List of players profiled in the report
- Arthrex, Inc.
- Zimmer Biomet
- Harvest Technologies Corporation
- DePuy Synthes, Inc.
- Stryker Corporation
- AdiStem Ltd.
- ISTO Biologics
- Cesca Therapeutics, Inc.
- Exactech Inc.
- Nuo Therapeutics
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
356.3. Opportunities
CHAPTER 4 PLATELET RICH PLASMA MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. PURE PRP
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. LEUKOCYTE RICH PRP
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. LEUKOCYTE RICH FIBRIN
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 PLATELET RICH PLASMA MARKET, BY ORIGIN
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. AUTOLOGOUS PRP
5.2.1. Market size and forecast
5.3. ALLOGENEIC PRP
5.3.1. Market size and forecast
5.4. HOMOLOGOUS PRP
5.3.1. Market size and forecast
CHAPTER 6 PLATELET RICH PLASMA MARKET, BY APPLICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. ORTHOPEDIC SURGERY
6.2.1. Market size and forecast
6.3. COSMETIC SURGERY
6.3.1. Market size and forecast
6.4. GENERAL SURGERY
6.4.1. Market size and forecast
6.5. NEUROSURGERY
6.5.1. Market size and forecast
6.6. OTHERS
6.6.1. Market size and forecast
CHAPTER 7 PLATELET RICH PLASMA MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.2.4. North America Platelet Rich Plasma Market by Product
7.2.5. North America Platelet Rich Plasma Market by Origin
7.2.6. North America Platelet Rich Plasma Market by Application
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast
7.3.4. Europe Platelet Rich Plasma Market by Product
7.3.5. Europe Platelet Rich Plasma Market by Origin
7.3.6. Europe Platelet Rich Plasma Market by Application
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast
7.4.4. Asia-Pacific Platelet Rich Plasma Market by Product
7.4.5. Asia-Pacific Platelet Rich Plasma Market by Origin
7.4.6. Asia-Pacific Platelet Rich Plasma Market by Application
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Latin America market size and forecast
7.5.3.2. Middle East market size and forecast
7.5.3.3. Africa market size and forecast
7.5.4. LAMEA Platelet Rich Plasma Market by Product
7.5.5. LAMEA Platelet Rich Plasma Market by Origin
7.5.6. LAMEA Platelet Rich Plasma Market by Application
CHAPTER 8 COMPANY PROFILES
8.1. ARTHREX, INC.
8.1.1. Operating business segments
8.1.3. Business performance
8.1.3. Key strategic moves and developments
8.3. ZIMMER BIOMET
8.3.1. Operating business segments
8.3.3. Business performance
8.3.3. Key strategic moves and developments
8.3. HARVEST TECHNOLOGIES CORPORATION
8.3.1. Operating business segments
8.3.3. Business performance
8.3.3. Key strategic moves and developments
8.4. DEPUY SYNTHES, INC.
8.4.1. Operating business segments
8.4.3. Business performance
8.4.3. Key strategic moves and developments
8.5. STRYKER CORPORATION
8.5.1. Operating business segments
8.5.3. Business performance
8.5.3. Key strategic moves and developments
8.6. ADISTEM LTD.
8.6.1. Operating business segments
8.6.3. Business performance
8.6.3. Key strategic moves and developments
8.7. ISTO BIOLOGICS
8.7.1. Operating business segments
8.7.3. Business performance
8.7.3. Key strategic moves and developments
8.8. CESCA THERAPEUTICS, INC.
8.8.1. Operating business segments
8.8.3. Business performance
8.8.3. Key strategic moves and developments
8.9. EXACTECH INC.
8.9.1. Operating business segments
8.9.3. Business performance
8.9.3. Key strategic moves and developments
8.10. NUO THERAPEUTICS
8.10.1. Operating business segments
8.10.3. Business performance
8.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Access from any device, anywhere
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
REQUEST TOC/SAMPLE
Purchase Full Report of
Platelet Rich Plasma Market- Global Opportunity Analysis and Industry Forecast, 2021-2028
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers